Notes to Consolidated Financial Statements

NOTE 13. RESEARCH EXPENDITURES

Research expenditures that related to the development of new products and processes, including significant improvements and refinements to existing products are expensed as incurred. Such costs were $61,471,000 in 2004, $53,171,000 in 2003 and $49,860,000 in 2002.